Evidence map›Paper›PMID 40636081›Full record

ArticleIn silico pharmacology2025

Exploring the therapeutic potential of

Ruchi Yadav, Nidhi Nambiar, Manushi Shah, Bhumika D Patel

Abstract read
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruchi YadavDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway, Chharodi, Ahmedabad, Gujarat 382481 India.
Nidhi Nambiar *Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382481 India.
Manushi Shah *Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat 382481 India.
Bhumika D PatelDepartment of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway, Chharodi, Ahmedabad, Gujarat 382481 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic condition caused by decreased insulin production and increased insulin resistance. Current treatments for T2DM include pharmacological agents and lifestyle modifications, but their clinical applications have become limited due to their side effects and high cost. Herbal remedies and natural products have become popular alternative treatments as they are associated with fewer side effects. Graphical abstract:

Indexed as

KarelaMD simulationMolecular dockingMomorcharaside BMomordicoside CNetwork pharmacologyPRKCDT2DM

Identifiers

PMID40636081
PMCPMC12234958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.